June 8, 2017August 24, 2022
Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

The antibiotic omadacycline has displayed an ability to fight treatment-resistant respiratory, skin and urinary-tract bacteria in preclinical-trial studies, according to its maker, ... Read more
June 6, 2017June 6, 2017
Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

A combination of Salvecin (AR-301) and antibiotics eradicated ventilator-associated bacterial pneumonia (VABP) better than antibiotics alone, according to a Phase ... Read more
June 1, 2017June 1, 2017
PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

The PPV23 vaccine, designed to protect against community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae, is not uniformly effective among the general ... Read more
May 30, 2017May 30, 2017
Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

A combination of three antibiotics can eradicate two of today’s six most treatment-resistant bacteria, according to researchers at the State University ... Read more
May 25, 2017May 25, 2017
Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

A new study urges hospital intensive care units (ICUs) to adopt safety and hygiene protocols to reduce the occurrence of ... Read more
May 23, 2017May 23, 2017
Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

An initial antibiotics regimen fails to cure pneumonia in one in four patients who acquire the disease outside hospitals and ... Read more
May 18, 2017May 18, 2017
Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

A key immune system component called memory T-cells contributes to the naturally occurring protection against pneumonia-causing bacteria that the body develops ... Read more
May 16, 2017May 16, 2017
Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

The risk of having a heart attack increases 17 times in the seven days after a respiratory infection, including pneumonia, ... Read more
May 11, 2017May 11, 2017
Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

Doctors Without Borders will conduct a clinical study on ResApp Health‘s respiratory disease app ResAppDx in a lower-income rural setting, the ... Read more
May 9, 2017May 9, 2017
PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

PaxVax is modernizing a pneumonia virus vaccine that hasn’t been updated in 30 years, partly to help protect military recruits. Because ... Read more
May 4, 2017May 4, 2017
T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

T-follicular helper cells generate antibodies that prevent people from getting pneumococcal pneumonia, according to a Australian study whose findings offer important ... Read more
May 2, 2017May 2, 2017
Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests

Patients with community-acquired pneumonia (CAP) and treated with penicillin-G/V had less severe pneumonia than patients treated with broad-spectrum antibiotics or ... Read more

June 8, 2017August 24, 2022

Omadacycline Shows Punch Against Drug-Resistant Bacteria, Studies Indicate

The antibiotic omadacycline has displayed an ability to fight treatment-resistant respiratory, skin and urinary-tract bacteria in preclinical-trial studies, according to its maker, Paratek’s Pharmaceuticals. The company presented the results, which include omadacycline’s ... Read more

June 6, 2017June 6, 2017

Salvecin and Antibiotics Combo Eradicates Pneumonia Better Than Antibiotics Alone, Phase 2a Trial Shows

A combination of Salvecin (AR-301) and antibiotics eradicated ventilator-associated bacterial pneumonia (VABP) better than antibiotics alone, according to a Phase 2a clinical trial. In addition, patients treated with the combo ... Read more

June 1, 2017June 1, 2017

PPV23 Vaccine’s Effectiveness Against Community-acquired Pneumonia Not Yet Consistent, Researchers Say

The PPV23 vaccine, designed to protect against community-acquired pneumonia (CAP) caused by Streptococcus pneumoniae, is not uniformly effective among the general population, immuno-compromised individuals and those with underlying risk factors, according ... Read more

May 30, 2017May 30, 2017

Triple-Antibiotic Combos Eliminate Two Treatment-Resistant Bacteria

A combination of three antibiotics can eradicate two of today’s six most treatment-resistant bacteria, according to researchers at the State University of New York at Buffalo. Drug-resistant pneumonia returned after being ... Read more

May 25, 2017May 25, 2017

Adapting Safety, Hygiene Protocols Prevents Pneumonia, Other Ventilator-Associated Illnesses in Hospital ICUs

A new study urges hospital intensive care units (ICUs) to adopt safety and hygiene protocols to reduce the occurrence of blood clots, lung damage or pneumonia infections when using mechanical ventilators. ... Read more

May 23, 2017May 23, 2017

Initial Antibiotic Treatment Fails in Nearly One in Four Pneumonia Patients, Study Finds

An initial antibiotics regimen fails to cure pneumonia in one in four patients who acquire the disease outside hospitals and care facilities, according to a study. The failures lead to ... Read more

May 18, 2017May 18, 2017

Memory T-Cells Contribute to Body’s Naturally Acquired Immunity Against Pneumonia During Childhood, Study Suggests

A key immune system component called memory T-cells contributes to the naturally occurring protection against pneumonia-causing bacteria that the body develops during childhood, according to a study. The research, “Regionally compartmentalized ... Read more

May 16, 2017May 16, 2017

Risk of Heart Attack Increases 17 Times in Week Following Respiratory Infection

The risk of having a heart attack increases 17 times in the seven days after a respiratory infection, including pneumonia, according to recent research from Australia. The study, “Triggering of ... Read more

May 11, 2017May 11, 2017

Respiratory Disease App to Be Evaluated by Doctors Without Borders in Low-income Rural Areas

Doctors Without Borders will conduct a clinical study on ResApp Health‘s respiratory disease app ResAppDx in a lower-income rural setting, the company announced. The study will evaluate ResAppDx for its diagnostic ... Read more

May 9, 2017May 9, 2017

PaxVax Updating 30-Year-Old Vaccine Against Pneumonia Virus That Can Hit Military Recruits

PaxVax is modernizing a pneumonia virus vaccine that hasn’t been updated in 30 years, partly to help protect military recruits. Because the virus often impacts recruits, the armed forces is blessing ... Read more

May 4, 2017May 4, 2017

T-Follicular Helper Cells Critical in Protecting Against Pneumococcal Pneumonia, Australian Study Shows

T-follicular helper cells generate antibodies that prevent people from getting pneumococcal pneumonia, according to a Australian study whose findings offer important insights on why some people are more vulnerable to the ... Read more

May 2, 2017May 2, 2017

Penicillin-G/V May Reduce Pneumonia Severity and Mortality, Study Suggests

Patients with community-acquired pneumonia (CAP) and treated with penicillin-G/V had less severe pneumonia than patients treated with broad-spectrum antibiotics or combination therapy, according to a new study conducted in Denmark. The findings, “Penicillin ... Read more